title: Lack of interferon production by dipyridamole.
abstract: Dipyridamole, previously reported to be an interferon (IFN) inducer in mice, was evaluated in 43 normal volunteers or cancer patients. At doses ranging from 150 mg orally to 887 mg intravenously, no serum antiviral activity suggesting IFN induction was observed.
authors: University of Wisconsin Clinical Cancer Center, Madison 53792.
authors: K A
authors: KA
authors: Havlin
authors: A D
authors: AD
authors: Inglot
authors: J K
authors: JK
authors: Willson
authors: E C
authors: EC
authors: Borden
authors: S
authors: S
authors: Grossberg
authors: B
authors: B
authors: Szulc
authors: A
authors: A
authors: Gladysz
authors: B
authors: B
authors: Groehlich
mesh_terms: D004176:Dipyridamole / Q000494:pharmacology*; D006801:Humans; D007369:Interferon Inducers
chemical_list: D007369:Interferon Inducers; D004176:Dipyridamole